ALTIMMUNE, INC. Deferred Rent Credit, Current
ALTIMMUNE, INC. (ALT) had Deferred Rent Credit, Current of $175.49 thousand as of 2018-12-31, per its 10-K filed 2020-03-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRentCreditCurrent · last filed 2020-03-27
- 2018-12-31: Deferred Rent Credit, Current $175.49K.
- 2018-09-30: Deferred Rent Credit, Current $173.95K.
- 2018-06-30: Deferred Rent Credit, Current $172.41K.
- 2018-03-31: Deferred Rent Credit, Current $19.39K.
| Period end | Deferred Rent Credit, Current |
|---|---|
| 2018-12-31 | $175.49K 10-K · filed 2020-03-27 |
| 2018-09-30 | $173.95K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $172.41K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $19.39K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $15.91K 10-K · filed 2019-04-01 |
| 2017-09-30 | $18.63K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $17.21K 10-Q · filed 2017-08-14 |
| 2016-12-31 | $14.39K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |